应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EIKN Eikon Therapeutics
交易中 02-11 15:36:03 EST
14.47
+0.88
+6.44%
最高
14.55
最低
13.29
成交量
26.28万
今开
13.60
昨收
13.59
日振幅
9.31%
总市值
7.30亿
流通市值
2.56亿
总股本
5,045万
成交额
363.71万
换手率
1.48%
流通股本
1,770万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
美股异动 | Eikon Therapeutics(EIKN.US)登陆纳斯达克 开盘跌超5%
智通财经 · 02-06
美股异动 | Eikon Therapeutics(EIKN.US)登陆纳斯达克 开盘跌超5%
生物医药公司Eikon Therapeutics(EIKN.US)IPO定价18美元募资3.812亿 今晚登陆纳斯达克
智通财经 · 02-05
生物医药公司Eikon Therapeutics(EIKN.US)IPO定价18美元募资3.812亿 今晚登陆纳斯达克
加载更多
公司概况
公司名称:
Eikon Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Eikon Therapeutics, Inc.于2019年7月9日在特拉华州注册成立。该公司是一家后期临床生物制药公司,旨在开发创新药物,以解决重大未满足的医疗需求。该组织主要专注于肿瘤学,推进一系列候选药物,旨在满足大适应症内的高未满足需求。该领导班子有着成功研发有冲击力药物的显著历史。该公司的战略包括利用专有技术平台创造新疗法,其主要候选药物针对晚期黑色素瘤和非小细胞肺癌等严重疾病。
发行价格:
--
{"stockData":{"symbol":"EIKN","market":"US","secType":"STK","nameCN":"Eikon Therapeutics","latestPrice":14.465,"timestamp":1770842121728,"preClose":13.59,"halted":0,"volume":262814,"delay":0,"changeRate":0.06438557763061074,"floatShares":17700000,"shares":50454737,"eps":0,"marketStatus":"交易中","change":0.875,"latestTime":"02-11 15:36:03 EST","open":13.6,"high":14.55,"low":13.285,"amount":3637089.5163499997,"amplitude":0.093083,"askPrice":14.53,"askSize":1647,"bidPrice":14.4,"bidSize":747,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1770267600000,"exchange":"NASDAQ","adjPreClose":13.59,"preHourTrading":{"tag":"盘前","latestPrice":13.5001,"preClose":13.59,"latestTime":"09:20 EST","volume":476,"amount":6459.321428,"timestamp":1770819643964,"change":-0.0899,"changeRate":-0.006615,"amplitude":0.006623},"postHourTrading":{"tag":"盘后","latestPrice":13.61,"preClose":13.59,"latestTime":"19:02 EST","volume":290,"amount":3955.9967,"timestamp":1770768137399,"change":0.02,"changeRate":0.001472,"amplitude":0.001472},"volumeRatio":0.16941},"requestUrl":"/m/hq/s/EIKN","defaultTab":"news","newsList":[{"id":"2609258870","title":"美股异动 | Eikon Therapeutics(EIKN.US)登陆纳斯达克 开盘跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609258870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609258870?lang=zh_cn&edition=full","pubTime":"2026-02-06 00:13","pubTimestamp":1770308025,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周四,Eikon Therapeutics(EIKN.US)登陆纳斯达克,开盘跌超5%,报17.05美元,IPO价格为18美元。Eikon Therapeutics由诺贝尔化学奖得主Eric Betzig、Xavier Darzacq、Luke Lavis和Robert Tjian于2019年创立,公司目前正布局多款癌症实验性疗法研发管线。公司研发进度最快的候选药物EIK1001,正与默沙东(MRK.US)的Keytruda联合开展一款皮肤癌的中后期临床试验,该研究的中期分析数据预计将于2026年下半年公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QQQE","QQQJ","NVIW.SI","BK4535","BK4581","BK4007","SRTY","BK4588","BK4539","QQQY","QYLG","TSYW.SI","PSQ","GPIQ","IWN","QYLD","BK4139","USAW.SI","UWM","BK1147","RWM","JEPQ","USJW.SI","TZA","SQQQ","IWO","BK4550","BK4585","TNA","MNQmain","QLD","QID","TQQQ","BK4534","EIKN","TWM"],"gpt_icon":0},{"id":"2609326107","title":"生物医药公司Eikon Therapeutics(EIKN.US)IPO定价18美元募资3.812亿 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2609326107","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609326107?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:14","pubTimestamp":1770275686,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,生物医药公司Eikon Therapeutics周三表示,其美国首次公开发行募资3.812亿美元,共发行约2120万股普通股,发行价定为每股18美元。而今年初,生物科技企业IPO同样迎来复苏,SpyGlass Pharma、AgomAb Therapeutics等生物医药研发企业均已在1月递交美国上市申请。Eikon Therapeutics由诺贝尔化学奖得主Eric Betzig、Xavier Darzacq、Luke Lavis和Robert Tjian于2019年创立,公司目前正布局多款癌症实验性疗法研发管线。Eikon Therapeutics的股票将于周四在纳斯达克挂牌交易,股票代码为“EIKN”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"189b8e4ee2abd43b1a3c2e363b7669dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物医药公司Eikon Therapeutics(EIKN.US)IPO定价18美元募资3.812亿 今晚登陆纳斯达克","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EIKN","USAW.SI","QQQE","SQQQ","PSQ","QYLG","USJW.SI","QQQJ","BK4588","QID","TQQQ","BK1147","QYLD","NVIW.SI","BK4139","MNQmain","BK4007","JEPQ","TSYW.SI","QQQY","BK4539","GPIQ","BK4585","QLD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.eikontx.com","stockEarnings":[{"period":"1week","weight":-0.245},{"period":"ytd","weight":-0.245}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Eikon Therapeutics, Inc.于2019年7月9日在特拉华州注册成立。该公司是一家后期临床生物制药公司,旨在开发创新药物,以解决重大未满足的医疗需求。该组织主要专注于肿瘤学,推进一系列候选药物,旨在满足大适应症内的高未满足需求。该领导班子有着成功研发有冲击力药物的显著历史。该公司的战略包括利用专有技术平台创造新疗法,其主要候选药物针对晚期黑色素瘤和非小细胞肺癌等严重疾病。","exchange":"NASDAQ","name":"Eikon Therapeutics","nameEN":"Eikon Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eikon Therapeutics(EIKN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eikon Therapeutics(EIKN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eikon Therapeutics,EIKN,Eikon Therapeutics股票,Eikon Therapeutics股票老虎,Eikon Therapeutics股票老虎国际,Eikon Therapeutics行情,Eikon Therapeutics股票行情,Eikon Therapeutics股价,Eikon Therapeutics股市,Eikon Therapeutics股票价格,Eikon Therapeutics股票交易,Eikon Therapeutics股票购买,Eikon Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eikon Therapeutics(EIKN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eikon Therapeutics(EIKN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}